Carolinas Wealth Consulting’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,467
| Closed | -$44K | – | 413 |
|
|
2025
Q1 | $44K | Hold |
3,467
| – | – | 0.01% | 368 |
|
|
2024
Q4 | $45.5K | Hold |
3,467
| – | – | 0.01% | 377 |
|
|
2024
Q3 | $52.3K | Hold |
3,467
| – | – | 0.01% | 356 |
|
|
2024
Q2 | $49.1K | Hold |
3,467
| – | – | 0.01% | 370 |
|
|
2024
Q1 | $47.3K | Hold |
3,467
| – | – | 0.01% | 383 |
|
|
2023
Q4 | $46.7K | Hold |
3,467
| – | – | 0.01% | 345 |
|
|
2023
Q3 | $40.2K | Hold |
3,467
| – | – | 0.01% | 338 |
|
|
2023
Q2 | $46.9K | Hold |
3,467
| – | – | 0.01% | 355 |
|
|
2023
Q1 | $48.3K | Hold |
3,467
| – | – | 0.01% | 369 |
|
|
2022
Q4 | $49.3K | Hold |
3,467
| – | – | 0.01% | 361 |
|
|
2022
Q3 | $47K | Hold |
3,467
| – | – | 0.01% | 332 |
|
|
2022
Q2 | $49K | Hold |
3,467
| – | – | 0.01% | 332 |
|
|
2022
Q1 | $57K | Hold |
3,467
| – | – | 0.01% | 330 |
|
|
2021
Q4 | $67K | Buy |
3,467
+597
| +21% | +$11.5K | 0.01% | 321 |
|
|
2021
Q3 | $60K | Buy |
+2,870
| New | +$60K | 0.01% | 318 |
|